eb-001
Biologicalexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2016 (NCT02939326)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Botulinum neurotoxin type ASupplementation
botA supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- eb-001
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03346902 | Phase 2 | Feb 6, 2018 | Bonti, Inc. |
| NCT03193593 | Phase 2 | Jul 23, 2017 | Bonti, Inc. |
| NCT02939326 | Phase 2 | Dec 1, 2016 | Bonti, Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bonti, Inc. | For profit | 3 | 3 | 1 | 2016 |
1 organizations
Page 1 / 1